1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
RSU Grants Approved for Board Members at Petros Pharmaceuticals
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
News, Letter Re Change in Certifying Accountant
Announces Unaudited Pro Forma Consolidated Balance Sheets
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws
Articles of Incorporation, Material Contracts, News
Notice of Late Filing for Annual Report
Q3
Q2
Q1
FY 2024
FY 2023 amended
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRER14A
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
Submission Upload
Correspondence